Patents by Inventor Niels Langeland Johansen

Niels Langeland Johansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel GLP-1 Derivatives
    Publication number: 20130244931
    Abstract: Novel polypeptide derivatives having protracted profile of action.
    Type: Application
    Filed: May 28, 2013
    Publication date: September 19, 2013
    Inventors: Jesper Lau, Thomas Kruse Hansen, Kjeld Madsen, Paw Bloch, Florencio Zaragoza Dorwald, Niels Langeland Johansen
  • Transglutaminase Mediated Conjugation of Growth Hormone
    Publication number: 20100197573
    Abstract: A method for PEGylating growth hormone, said method comprising reacting growth hormone with an amine comprising nucleophile which further comprises a first functional group in the presence og TGase to form a transaminated growth hormone, followed by a reaction of said transaminated growth hormone with a PEG which has been functionalised with a second functional group, wherein said first and second functional groups are selected so that they react to form a covalent bond.
    Type: Application
    Filed: June 15, 2006
    Publication date: August 5, 2010
    Applicant: Novo Nordisk Health Care AG
    Inventors: Florencio Zaragoza Dorwald, Niels Langeland Johansen, Lars Fogh Iversen